Investors searching for reliable dividend income have three compelling options standing well above the S&P 500’s current yield of just 1%.
Novo Nordisk (NYSE: NVO) carries a trailing 12-month dividend payout ratio of 40%, which provides meaningful cushion even as the company navigates a shifting competitive landscape.
The Danish drugmaker was first to market with a GLP-1 weight-loss injection, but lost its early lead to rival Eli Lilly in that fast-growing drug category.
Novo Nordisk has since moved ahead of Eli Lilly in the GLP-1 pill segment, and its oral treatment appears to outperform Eli Lilly’s competing pill in early comparisons.
That development gives Novo Nordisk a real opportunity to reclaim market share in one of the pharmaceutical industry’s most closely watched drug niches.
Growth is expected to be slow given the company’s sheer size, but a 3.5% dividend yield makes it an attractive foundation for income-focused portfolios heading into the second half of 2026.
Enterprise Products Partners (NYSE: EPD), one of the largest midstream energy businesses in North America, offers investors a yield of 5.9% with relatively low exposure to commodity price swings.
Unlike producers directly tied to oil prices, midstream operators like Enterprise Products Partners generate revenue primarily from transporting and processing energy, which insulates the business from the volatility that has defined global energy markets amid ongoing geopolitical tensions in the Middle East.
Realty Income (NYSE: O) rounds out the list with a 5% yield and a structure specifically designed to deliver consistent income to shareholders month after month.
As a real estate investment trust, Realty Income is legally required to distribute at least 90% of its annual taxable income to shareholders, giving the dividend legal and structural backing most other equities cannot match.
The company pays its dividend on a monthly basis, a feature that distinguishes it from most dividend stocks and appeals particularly to retirees and income-dependent investors.
Realty Income has increased its dividend every year since 1994, a track record spanning multiple recessions, rate cycles, and periods of market stress.
Novo Nordisk suits investors comfortable buying out-of-favor names with strong underlying fundamentals, while Realty Income targets conservative income seekers who prioritize reliability over growth.
Enterprise Products Partners fills the space for investors who want energy sector exposure without taking on the commodity price risk that comes with upstream producers.
Together, the three stocks span pharmaceuticals, real estate, and energy infrastructure, offering income investors meaningful diversification alongside yields that dwarf the broader market benchmark.
